Everest Pharmaceuticals Ltd.
Abemaciclib Cancer (oncology)
Originator: Verzenio · Eli Lilly and Company (Lilly USA, LLC)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Abemaxen | 150 mg and 200 mg tablets | — | — | — | — |
Alectinib Cancer (oncology)
Originator: Alecensa · Roche (Genentech in the US; originated by Chugai Pharmaceutical)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Alecnib | 150 mg capsule | — | — | — | — |
| Alecnib | 150 mg | Capsule | BDT 500 | US$4.07 | 1 x 56: ৳ 28,000.00 |
Baricitinib Immunology & rheumatology
Originator: Olumiant · Eli Lilly and Company (co-developed with Incyte; initial U.S. approval 2018)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Barixen | 2 mg | Tablet | BDT 25 | US$0.20 | 2 x 10: ৳ 500.00 |
Capmatinib Cancer (oncology)
Originator: Tabrecta · Novartis (discovered by Incyte, licensed to Novartis in 2009)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Capmaxen | 200 mg | Tablet | BDT 1,500 | US$12.21 | 1 x 28: ৳ 42,000.00 |
Crizotinib Cancer (oncology)
Originator: Xalkori · Pfizer
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Alkixen | 250 mg capsule | — | — | — | — |
| Alkixen | 250 mg | Capsule | BDT 350 | US$2.85 | 1 x 30: ৳ 10,500.00 |
Empagliflozin Diabetes & metabolic
Originator: Jardiance · Boehringer Ingelheim, co-marketed with Eli Lilly and Company (licensed from Boehringer Ingelheim International GmbH)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Empoli | 10 mg | Tablet | BDT 25 | US$0.20 | 2 x 10: ৳ 500.00 |
| Empoli | 25 mg | Tablet | BDT 50 | US$0.41 | 1 x 10: ৳ 500.00 |
Ibrutinib Cancer (oncology)
Originator: Imbruvica · Pharmacyclics LLC (an AbbVie company) and Janssen Biotech, Inc. (Johnson & Johnson) - developed and commercialised jointly; US distributor of record: Pharmacyclics LLC
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Ibruxen | 140 mg capsule | — | — | — | — |
| Ibruxen | 140 mg | Capsule | BDT 350 | US$2.85 | 1 x 30: ৳ 10,500.00 |
Lorlatinib Cancer (oncology)
Originator: Lorbrena · Pfizer Inc.
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Lorbrexen | 100 mg tablet | — | — | — | — |
| Lorbrexen | 100 mg | Tablet | BDT 1,660 | US$13.51 | 1 x 30: ৳ 49,800.00 |
Niraparib Cancer (oncology)
Originator: Zejula · GlaxoSmithKline (GSK); originally developed by Tesaro (Tesaro UK Limited)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Niranib | 100 mg capsule | — | — | — | — |
| Niranib | 100 mg | Capsule | BDT 1,000 | US$8.14 | 1 x 30: ৳ 30,000.00 |
Olaparib Cancer (oncology)
Originator: Lynparza · AstraZeneca (distributed by AstraZeneca Pharmaceuticals LP); developed and commercialised in collaboration with Merck (MSD outside the US and Canada)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Olanib | 150 mg tablet and 50 mg capsule | — | — | — | — |
| Olanib | 150 mg | Tablet | BDT 400 | US$3.26 | 1 x 30: ৳ 12,000.00 |
| Olanib | 50 mg | Capsule | BDT 130 | US$1.06 | 1 x 112: ৳ 14,560.00 |
Osimertinib Cancer (oncology)
Originator: Tagrisso · AstraZeneca
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Osimert | 80 mg tablet | — | — | — | — |
| Osimert | 80 mg | Tablet | BDT 333 | US$2.71 | 1 x 14: ৳ 4,662.00 |
Palbociclib Cancer (oncology)
Originator: Ibrance · Pfizer Inc. (Pfizer Laboratories Div Pfizer Inc)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Palboxen | 125 mg capsule | — | — | — | — |
| Palboxen | 125 mg | Capsule | BDT 400 | US$3.26 | 1 x 21: ৳ 8,400.00 |
Sofosbuvir/Velpatasvir Antivirals (hepatitis C)
Originator: Epclusa · Gilead Sciences (Gilead Sciences Ireland UC for the EU)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Velpanex | 400 mg + 100 mg tablet | — | — | — | — |
| Velpanex | 400 mg+100 mg | Tablet | BDT 1,000 | US$8.14 | 1 x 7: ৳ 7,000.00 |
Sotorasib Cancer (oncology)
Originator: Lumakras · Amgen
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Sotoxen | 120 mg | Tablet | BDT 1,000 | US$8.14 | 1 x 56: ৳ 56,000.00 |
Tofacitinib Immunology & rheumatology
Originator: Xeljanz / Xeljanz XR · Pfizer (initial U.S. approval 2012)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Tofaxen | 5 mg | Tablet | BDT 48 | US$0.39 | 1 x 14: ৳ 672.00 |
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.